Compare OSCR & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OSCR | ITGR |
|---|---|---|
| Founded | 2012 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.0B |
| IPO Year | 2021 | 2000 |
| Metric | OSCR | ITGR |
|---|---|---|
| Price | $13.16 | $83.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $17.00 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 6.1M | 847.9K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.89 |
| Revenue | ★ $11,701,427,000.00 | $1,853,637,000.00 |
| Revenue This Year | $63.73 | $1.69 |
| Revenue Next Year | $5.40 | $6.53 |
| P/E Ratio | ★ N/A | $28.84 |
| Revenue Growth | ★ 27.50 | 7.98 |
| 52 Week Low | $11.20 | $62.00 |
| 52 Week High | $23.80 | $127.56 |
| Indicator | OSCR | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 44.24 |
| Support Level | $12.47 | $82.78 |
| Resistance Level | $15.11 | $87.54 |
| Average True Range (ATR) | 0.68 | 2.73 |
| MACD | 0.00 | -0.43 |
| Stochastic Oscillator | 34.12 | 14.66 |
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.